Rapamycin-induced endothelial cell death and tumor vessel thrombosis potentiate cytotoxic therapy against pancreatic cancer. [electronic resource]
Producer: 20041221Description: 2109-19 p. digitalISSN:- 1078-0432
- Angiogenesis Inhibitors -- therapeutic use
- Animals
- Blood Flow Velocity -- drug effects
- Cell Death
- Cell Division -- drug effects
- Deoxycytidine -- analogs & derivatives
- Endothelium, Vascular -- drug effects
- Humans
- Male
- Mice
- Mice, Nude
- Neovascularization, Pathologic -- drug therapy
- Pancreatic Neoplasms -- blood supply
- Sirolimus -- therapeutic use
- Transplantation, Heterologous
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.